WordNet

something having the property of being analogous to something else (同)analog, parallel
of a circuit or device having an output that is proportional to the input; "analogue device"; "linear amplifier" (同)analog, linear

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

Therapeutic uses of somatostatin and its analogues: Current view and potential applications.

Rai U1, Thrimawithana TR2, Valery C2, Young SA2.
Pharmacology & therapeutics.Pharmacol Ther.2015 Aug;152:98-110. doi: 10.1016/j.pharmthera.2015.05.007. Epub 2015 May 5.
Somatostatin is an endogeneous cyclic tetradecapeptide hormone that exerts multiple biological activities via five ubiquitously distributed receptor subtypes. Classified as a broad inhibitory neuropeptide, somatostatin has anti-secretory, anti-proliferative and anti-angiogenic effects. The clinical
PMID 25956467

Preoperative somatostatin analogues versus direct transsphenoidal surgery for newly-diagnosed acromegaly patients: a systematic review and meta-analysis using the GRADE system.

Nunes VS1, Correa JM, Puga ME, Silva EM, Boguszewski CL.
Pituitary.Pituitary.2015 Aug;18(4):500-8. doi: 10.1007/s11102-014-0602-9.
Whether the preoperative use of somatostatin analogues (SA) improves surgical outcomes in acromegaly is still a matter of debate.OBJECTIVE: We conducted a systematic review of randomized, controlled trials that compared the short-term outcomes of preoperative use of SA (Pre-SA) with direct TSS (No-S
PMID 25261979

Heart rate variability is reduced in acromegaly patients and improved by treatment with somatostatin analogues.

Comunello A1, Dassie F, Martini C, De Carlo E, Mioni R, Battocchio M, Paoletta A, Fallo F, Vettor R, Maffei P.
Pituitary.Pituitary.2015 Aug;18(4):525-34. doi: 10.1007/s11102-014-0605-6.
BACKGROUND: Cardiovascular complications, including arrhythmias and cardiac sudden death, are the most common causes of enhanced mortality in acromegaly. However, few data are available on cardiac autonomic functions and sympathovagal balance in acromegalic patients.OBJECTIVE: The aim of this study
PMID 25261332

OKI Yutaka
Neurologia medico-chirurgica, 2014
… In patients with acromegaly, dopamine agonists, somatostatin analogues, and growth hormone receptor antagonist have been used as a monotherapy or the combination, and the high remission rate can be achieved. … Pasireotide having high affinity to type 5 somatostatin receptors will be available for the patients presenting resistance against type 2 receptor agonists, such as octreotide and lanreotide. …
NAID 130004922291

OKI Yutaka
Neurologia medico-chirurgica 54(12), 958-965, 2014
… In patients with acromegaly, dopamine agonists, somatostatin analogues, and growth hormone receptor antagonist have been used as a monotherapy or the combination, and the high remission rate can be achieved. … Pasireotide having high affinity to type 5 somatostatin receptors will be available for the patients presenting resistance against type 2 receptor agonists, such as octreotide and lanreotide. …
NAID 130004704540

Expressions of Somatostatin Receptor Subtypes (SSTR-1, 2, 3, 4 and 5) in Neuroblastic Tumors; Special Reference to Clinicopathological Correlations with International Neuroblastoma Pathology Classification and Outcomes

Watanabe Noriko,Nakanishi Yoko,Kinukawa Noriko,Ohni Sumie,Obana Yukari,Nakazawa Atsuko,Nemoto Norimichi
ACTA HISTOCHEMICA ET CYTOCHEMICA 47(5), 219-229, 2014
… Somatostatin receptor (SSTR) expressions in neuroblastomas (NBs) have been confirmed employing various methods. … However, even those in the unfavorable histology group with NBs expressing SSTR are good candidates for molecular targeting therapy using somatostatin analogues. …
NAID 130004687245